期刊文献+

有丝分裂核碎裂指数在节细胞神经母细胞瘤预后评价中的意义及其与Ki67表达的相关性

Relationship between the Expression of Ki67 and Mitosis Karyorrhexis Index in Ganglioneuroblastoma
下载PDF
导出
摘要 目的探讨有丝分裂核碎裂指数(MKI)在节细胞神经母细胞瘤(GNB)预后评价中的意义及其与细胞增殖抗原标记物Ki67的相关性。方法收集28例GNB的标本和临床资料。显微镜下计数每例标本的MKI,应用免疫组织化学方法检测每例标本中Ki67蛋白的表达。根据2003年国际神经母细胞瘤病理分类标准进行病理分型和统计学分析。结果 28例GNB预后良好型15例,预后不良型13例。随访28例,失访1例。预后良好型GNB患者组生存时间明显高于预后不良组(P<0.05),生存时间与病理分型显著相关(P<0.05)。MKI与临床分期、病理分型以及生存时间相关(P<0.05)。高MKI组与低MKI组相比,Ki67表达无显著差异。结论在GNB的病理分型和预后评价中,MKI是一个显著的预后评价指标,单独检测Ki67对预后评价意义不大。 Objective To explore the relationship between the expression of Ki67 and mitosis karyorrhexis index(MKI)in ganglioneuroblastoma(GNB).Methods Clinical materials and histology slides from 28 patients with GNB were reviewed.MKI was counted under microscope and the expression of Ki67 protein in GNB was evaluated by immuohistochemical technique.The follow-up data were also collected and statistically analyzed.Results There were 15 patients with favourite prognosis(favourite subgroup,FS) and 13 patients with poor prognosis(unfavourite subgroup,US).The survival time of GNB patient in FS was significantly longer than that in US(P 0.05).The survival time is related to pathology classification(P 0.05).MKI was correlated with advanced clinical stage,pathology classification and survival time(P 0.001).No significant difference in Ki67 expression was found between low and high MKI patients.Conclusion MKI might be a reliable prognostic parameter for making diagnosis and evaluating prognosis of GNB.Detection of Ki67 expression might be not useful for evaluating the prognosis of GNB.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2010年第6期481-484,共4页 Journal of China Medical University
关键词 节细胞神经母细胞瘤 细胞增殖抗原标记物 预后 有丝分裂核碎裂指数 ganglioneuroblastoma proliferating cell antigen prognosis mitosis karyorrhexis index
  • 相关文献

参考文献8

  • 1Peuchmaur M, d' Amore ES,..loshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular[ J ]. Cancer, 2003,98(10) : 2274-2281.
  • 2Uccini S, Colarossi C, Scarpino S, et al. Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours [ J ]. Br J Cancer, 2006,95 (6):49-55.
  • 3段光杰,柳凤轩,阎晓初,李娴.腹膜后结节型节细胞神经母细胞瘤l例报道及文献复习[J].诊断病理学杂志,2004,11(2):87-89. 被引量:7
  • 4Shimada H, Umehara S, Monobe Y, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors:a report from the Children's Cancer Group [ J ]. Cancer, 2001,92 ( 9 ) : 2451-2461.
  • 5Umehara S, Nakagawa A, Matthay KK,et al. Histopathology defines prognostic subsets of ganglioneuroblastoma,nodular [J]. Cancer, 2000,89(5): 1150-1161.
  • 6Gestbhan C, Hoehner JC, Pahlman S. Proliferation and apoptosis in neuroblastoma : subdividing the mitosis-karyorrhexis index [ J ]. Eur J Cancer, 1995,31A(4) :458-463.
  • 7Chamdin A,Jarzembowski JA,Subramanian C,et al. Bc16 is expressed in neuroblastoma:tumor cell type-specific expression predicts outcome [ J ]. Transl Oncol, 2009,2 (3) : 128-137.
  • 8Coco S,Tonini GP, Stigliani S, et al. Genome and transeriptome analysis of neuroblastoma advanced diagnosis from innovative therapies [ J ]. Curr Pharm Des, 2009, 15 (4) : 448-455.

二级参考文献9

  • 1Stout AP.Ganglioneuroma of the sympathetic nervous system[J].Surg Gynecol Obstet,1947,84(1):101-110.
  • 2Adam A,Hochholzer L.Ganglioneuroblastoma of the posterior mediastinum:a clinicopathologic review of 80 cases[J].Cancer,1981,47(2):373-381.
  • 3Shimada H,Chatten J,Newton WA,et al. Histopathologic prognostic factors in neuroblastic tumors;definition of subtypes of ganglioneiroblstoma and an age-linked classification of neuroblastomas[J].J Natl Cancer Inst,1984,73(2):405-416.
  • 4Aoyama C,Qualman SJ,Regan M,et al. Histopathologic features of composite ganglioneuroblastoma:immunohistochemical distinction of the stromal component is related to prognosis[J].Cancer,1990,65(2):255-264.
  • 5Shimada H,Ambros IM,Dehner LP,et al. Terminology and morphologic criteria of neuroblastic tumors:recommendations by the International Neuroblastoma Pathology Committee[J].Cancer,1999,86(2):349-363.
  • 6Shimada H,Ambros IM,Dehner LP,et al. The International Neuroblastoma Pathology Classification(the Shimada system)[J].Cancer,1999,86(2):364-372.
  • 7Umehara S,Nakagawa A,Matthay KK,et al. Histopathology defines prognostic subsets of ganglioneuroblastoma,nodular[J].Cancer,2000,89(5):1150-1161.
  • 8李穗生,刘唐彬,周慕珩.神经母细胞瘤转化为节细胞神经瘤的临床观察[J].中华小儿外科杂志,2001,22(6):341-342. 被引量:15
  • 9高解春,周菊玲,陈莲.神经母细胞瘤组织分型的生物特性与临床意义[J].中华小儿外科杂志,2002,23(1):9-10. 被引量:3

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部